Filter
421
Text search:
rubella
Featured
Recommendations
45
New Publications
154
Language
Document type
No document type
251
Guidelines
55
Studies & Reports
48
Manuals
18
Strategic & Response Plan
14
Fact sheets
12
Situation Updates
11
Brochures
4
Training Material
3
Resource Platforms
2
Infographics
2
Online Courses
1
Countries / Regions
Bangladesh
18
Global
17
Nepal
15
Germany
12
Myanmar / Burma
12
Latin America and the Carribbean
11
India
10
South Africa
10
Ukraine
10
Philippines
9
Western and Central Europe
9
Sierra Leone
8
Zambia
8
Nigeria
7
Lesotho
7
Africa
6
Kenya
5
Tanzania
5
Rwanda
5
Indonesia
5
Liberia
4
South Sudan
4
Brazil
4
South–East Asia Region
4
Venezuela
4
Congo, Democratic Republic of
3
Ethiopia
3
Uganda
3
Malawi
3
East and Southern Africa
3
Russia
3
Cameroon
2
Zimbabwe
2
Jordan
2
Lebanon
2
Syria
2
Mozambique
2
Botswana
2
Yemen
2
Middle East and North Africa
2
Eastern Europe
2
Albania
2
Senegal
1
Mali
1
Ghana
1
Togo
1
Haiti
1
Iraq
1
Afghanistan
1
Turkey
1
Egypt
1
Cambodia
1
Papua New Guinea
1
Sudan
1
Argentina
1
Namibia
1
Peru
1
Eswatini/ Swaziland
1
North Macedonia
1
Colombia
1
Ecuador
1
Bolivia
1
Libya
1
Angola
1
Mexico
1
Chile
1
West and Central Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Paraguay
1
Solomon Islands
1
Bhutan
1
Timor Leste/ East Timor
1
Tajikistan
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
172
Clinical Guidelines
56
Women & Child Health
31
Public Health
20
Key Resources
9
Pharmacy & Technologies
5
Capacity Building
4
Toolboxes
COVID-19
44
Rapid Response
32
Refugee
29
Disability
22
Zika
20
Conflict
14
Mental Health
14
HIV
12
Ebola
10
Pharmacy
9
NTDs
9
Caregiver
7
Polio
5
AMR
5
Health Financing Toolbox
5
NCDs
5
TB
4
Natural Hazards
3
Planetary Health
3
Global Health Education
2
Case definitions, clinical classification, and disease phases Dengue, Chikungunya, and Zika
recommended
A person who lives in or has traveled in the previous 14 days to areas with dengue transmission, and presents with acute fever that has typically lasted 2 to 7 days, and two or more of the following clinical manifestations: nausea or vomiting, exanthema, headache or retro-orbital pain, myalgia or ar
...
This document seeks to help health communication professionals working on the topic of immunization more effectively communicate about Events Supposedly Attributed to Vaccination and Immunization (ESAVI) by building trust in National Immunization Programs, understanding risk perceptions related to v
...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy
...
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of
...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig
...
Since fighting between the Sudanese Armed Forces (SAF) and the Rapid Support Forces (RSF) erupted in mid-April, an estimated 6.3 million people have fled their homes, taking refuge inside and outside the country, with children representing about half of the people displaced. Sudan is now the country
...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm
...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si
...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh
...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt
...
The article focuses on "The State of the World’s Children 2023" report published by UNICEF. It highlights the critical role of vaccines in saving lives and the challenges in global immunization efforts, especially for marginalized and underserved children. The report emphasizes the impact of COVID
...
Diabetes is a major public health problem. The rising incidence of Diabetes Type 2 is related to the effects of urbanization and unhealthy lifestyles. Research studies show that healthy eating and regular physical activity can prevent or delay the onset of Diabetes Type 2, even in high-risk individu
...
Since the Alma Ata Declaration in 1978, community health volunteers (CHVs) have been at the forefront, providing health services, especially to underserved communities, in low-income countries. However, consolidation of CHVs position within formal health systems has proved to be complex and continue
...
Mpox continues to affect people around the world. A new framework released today by WHO will guide health authorities, communities and other stakeholders in preventing and controlling mpox outbreaks, eliminating human-to-human transmission of the disease, and reducing spillover of the virus from ani
...
The "Primary Healthcare Standard Treatment Guidelines and Essential Medicines List" by the South African National Department of Health provides evidence-based guidelines for diagnosing and managing common medical conditions at the primary healthcare level. This document includes treatment protocols
...
The purpose of this document is to present concise information on the current case definitions for dengue, chikungunya, and Zika proposed by PAHO, as well as information on the clinical phases and severity classification of dengue and chikungunya.
The Country Cooperation Strategy is the World Health Organization (WHO)’s reference for country work guiding planning and resource allocation through alignment with national health priorities and harmonization with other development partners. It clarifies roles and functions of WHO in supporting t
...
This document provides a list of key WHO-recommended maternal and newborn health commodities and aims to accelerate progress towards the SDGs. It consolidates the key and enabling commodities from existing WHO guidelines on maternal and newborn health.
This Birth Defect Surveillance facilitator (train-the-trainer) guide 2nd edition covers foundational skills needed to begin the development, implementation and ongoing improvement of a congenital anomaly surveillance programme, whether population-based or hospital-based, in particular for countries
...
Strengthening of vaccination interventions during and post-Health Emergency by SARS-CoV-2
General Objective
To strengthen vaccination interventions in the territory, during the COVID-19 health emergency, in order to emergency due to COVID-19, in order to prevent the reintroduction and maintain co
...
